Prostaglandin derivatives
US7273946B2 · kind B2 · utility
10Cited by
7References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2005 |
| Grant date | Sep 25, 2007 |
| Priority date | — |
| Expiry date | Oct 3, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.